With a FREE Account you can: Post live links, images, charts, etc.; Create & moderate your own Groups; Add members & posts to Favorites; Put trolls On Ignore or report them for abuse; View full threads; Private Message other members; & much more! No other free stock message board service even comes close!
Interesting Leerink report on why Orphan Drug companies (think CELG) are the "Golden Child of Biotech"
Huge 64 page report - here is summary. CELG is fiting on all cylinders and is in the right business - orphan cancer drugs and owns 100% of the rights of their drugs just as MAJOR markets not available to DNA when it hit 100 billion market cap - Turkey, Russia, Poland, Mexico, Brazil and of course China....
October 12, 2011
Reason for report:
Future of Orphan Drugs: The Golden Child of Biotech
Bottom Line: We believe that orphan drugs have advantages over